Related Experiment Video
Updated: Aug 6, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Interstitial lung disease: progress and problems
1Department of Respiratory Medicine, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK. Stephen.Bourke@nuth.northy.nhs.uk
Postgraduate Medical Journal
|August 8, 2006
Summary
Interstitial lung disease (ILD) diagnosis is complex, often requiring advanced imaging like high-resolution CT and sometimes surgical lung biopsy. Research continues to improve understanding and treatment of these challenging diffuse lung diseases.
Area of Science:
- Pulmonology
- Internal Medicine
- Radiology
Background:
- Interstitial lung disease (ILD) presents diagnostic challenges due to its association with comorbidities and systemic conditions.
- Patients typically exhibit dyspnea and diffuse chest radiograph abnormalities, necessitating a broad differential diagnosis.
Purpose of the Study:
- To review the diagnostic approaches and current challenges in managing interstitial lung diseases.
- To highlight the role of imaging and biopsy in ILD classification and patient care.
Main Methods:
- Review of diagnostic modalities including high-resolution computed tomography (HRCT) and bronchoalveolar lavage (BAL).
- Discussion of histopathological classification based on surgical lung biopsies.
- Analysis of clinical decision-making regarding invasive procedures.
Main Results:
- HRCT is crucial for characterizing ILD patterns and extent.
- BAL effectively excludes infectious causes of diffuse lung infiltrates.
- Surgical lung biopsies have informed a new histopathological classification system for previously termed cryptogenic fibrosing alveolitis.
Conclusions:
- Despite advances, challenges remain in determining the clinical utility of surgical lung biopsy.
- Further research is needed to elucidate ILD pathogenesis and develop more effective treatments.
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.